Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Aaron N. Hata's publication output changed over time?
ScholarIQpublication output · 2004–2024
Output grew0% over the shown period — from 1 works in 2004 to 1 in 2024.
1
2
2
1
2
2
1
1
20042015201620182020202120222024
What are the most-cited papers on Aaron N. Hata?
ScholarIQmost cited works
<i>EGFR</i> Mutations and <i>ALK</i> Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non–Small Cell Lung Cancer: A Retrospective Analysis
Justin F. Gainor, Alice T. Shaw, Lecia V. Sequist, Xiujun Fu, Christopher G. Azzoli, Zofia Piotrowska, Tiffany G. Huynh, Ling Zhao, Linnea Fulton, Katherine R. Schultz, Emily Howe, Anna F. Farago, Ryan J. Sullivan, James R. Stone, Subba R. Digumarthy, Teresa Morán, Aaron N. Hata, Yukako Yagi, Beow Y. Yeap, Jeffrey A. Engelman, Mari Mino–Kenudson
Clinical Cancer Research. 20161,254 CitationsOPEN ACCESS
Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition
Aaron N. Hata, Matthew J. Niederst, Hannah L. Archibald, María Gomez‐Caraballo, Faria M. Siddiqui, Hillary E. Mulvey, Yosef E. Maruvka, Fei Ji, Hyo-Eun Carrie Bhang, Viveksagar Krishnamurthy Radhakrishna, Giulia Siravegna, Haichuan Hu, Sana Raoof, Elizabeth L. Lockerman, Anuj Kalsy, Dana Lee, Celina L Keating, David A. Ruddy, Leah J. Damon, Adam Crystal, Carlotta Costa, Zofia Piotrowska, Alberto Bardelli, A. John Iafrate, Ruslan I. Sadreyev, Frank Stegmeier, Gad Getz, Lecia V. Sequist, Anthony C. Faber, Jeffrey A. Engelman
Nature Medicine. 20161,010 CitationsOPEN ACCESS
Pharmacology and signaling of prostaglandin receptors: Multiple roles in inflammation and immune modulation
Aaron N. Hata, Richard Breyer
Pharmacology & Therapeutics. 2004832 Citations
A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors
Michal Slyper, Caroline Porter, Orr Ashenberg, Julia Waldman, Eugene Drokhlyansky, Isaac Wakiro, Christopher S. Smillie, Gabriela Smith-Rosario, Jingyi Wu, Danielle Dionne, Sébastien Vigneau, Judit Jané‐Valbuena, Timothy L. Tickle, Sara Napolitano, Mei-Ju Su, Anand G. Patel, Åsa Karlström, Simon Gritsch, Masashi Nomura, Avinash Waghray, Satyen H. Gohil, Alexander M. Tsankov, Livnat Jerby‐Arnon, Ofir Cohen, Johanna Klughammer, Yanay Rosen, Joshua Gould, Lan Nguyễn, Matan Hofree, Peter J. Tramontozzi, Bo Li, Catherine J. Wu, Benjamin Izar, Rizwan Haq, F. Stephen Hodi, Charles H. Yoon, Aaron N. Hata, Suzanne J. Baker, Mario L. Suvà, Raphael Bueno, Elizabeth H. Stover, Michael R. Clay, Michael A. Dyer, Natalie B. Collins, Ursula A. Matulonis, Nikhil Wagle, Bruce E. Johnson, Asaf Rotem, Orit Rozenblatt–Rosen, Aviv Regev
Nature Medicine. 2020823 CitationsOPEN ACCESS
The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics
Aaron N. Hata, Jeffrey A. Engelman, Anthony C. Faber
Cancer Discovery. 2015629 CitationsOPEN ACCESS
Related on ScholarIQ
Harvard University
Institution
<i>EGFR</i> Mutations and <i>ALK</i> Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non–Small Cell Lung Cancer: A Retrospective Analysis
Paper
Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition
Paper
Pharmacology and signaling of prostaglandin receptors: Multiple roles in inflammation and immune modulation
Paper
A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors
Paper
The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics
Paper